Lilly Reports Solid Third-Quarter 2022 Financial Results and Continued Pipeline Progress

Go back to Lilly Reports Solid Third-Quarter 2022 Financial Results and Continued Pipeline Progress

Eli Lilly & Co. (LLY) Tops Q3 EPS by 7c; Offers FY22 EPS Guidance

November 1, 2022 6:27 AM EDT

Eli Lilly & Co. (NYSE: LLY) reported Q3 EPS of $1.98, $0.07 better than the analyst estimate of $1.91. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.91 billion.

GUIDANCE:

Eli Lilly & Co. sees FY2022 EPS of $7.70-$7.85, versus the... More